Key figures

  • No. 1 independent French pharmaceutical company

  • Over 21,000 employees, including nearly 3,000 in Research and Development, preparing the drugs of the future

  • In 2015, 24% of Servier’s turnover was invested in Research and Development

  • Servier is currently developing 23 drug candidates in oncology, cardiology, metabolic diseases, neuropsychiatry and rheumatology

  • Present in 148 countries over 5 continents

  • 92% of Servier's medicines are prescribed outside France
  • A turnover of 3.9 billion euros in 2015